Mithra's Donesta meets in Phase II for postmenopausal vasomotor symptoms

Mithra Pharmaceuticals S.A. (Euronext:MITRA) reported data from the Phase II E4 Relief trial to treat vasomotor symptoms in postmenopausal women showing that once-daily

Read the full 235 word article

User Sign In